Krishna Kittu Kolluri

Krishna Kittu Kolluri is mostly a buyer: 10 purchases, 8 of them with a reported amount, worth EUR 42,839,961 in total with a median of EUR 5,364,382, against a single sale, EUR 5,148, on October 31, 2016 at Ra Pharmaceuticals, Inc. Purchases make up 91% of the open-market trades filed. The three largest date from 2016: EUR 9,209,799 on January 12 at Epizyme, Inc., EUR 6,459,345 on December 19 at Achaogen, Inc. and EUR 6,021,273 on July 18 at Ardelyx, Inc.

The 60 filings split between BillionToOne, Inc. (45, title Director) and several companies where the reported title is 10% Owner: Ra Pharmaceuticals, Inc. (6), Ardelyx, Inc. (3), TESARO, Inc. (2) and Achaogen, Inc. (1). The record counts 46 filings of another kind and 3 grants.

Filings concentrate in 2016 (15), 2025 (12) and 2026 (33). They are published a median of 2 days after the trade. The 45 filings of the last twelve months include no purchase and no sale.

Kolluri's own market trades within 30 days of colleagues at Ardelyx, Inc. number 3, 3 and 3. All of them in the same direction. Colleagues in order: Anthony A. Florence Jr., David M. Mott and Forest Baskett.